The inhibitory effect of dantrolene sodium and propofol on 6-phosphogluconate dehydrogenase from rat erythrocyte

Fresenius Environmental Bulletin

Volumn 17, Issue 9 A, 2008, Pages 1283-1287

  Gülçin, Ilharni ^a   Beydemir, Şükrü ^a   Abdulkadir Coban T ^b   Ekhici, Deniz ^a  

^a ATATÜRK UNIVERSITY   (Turkey)

^b ERZINCAN UNIVERSITY   (Turkey)

Author keywords

6 phospogluconate dehydrogenase; Dantrolene; Erythrocytes; In vivo; Propofol

Indexed keywords

CYTOLOGY; DRUG; ENZYME ACTIVITY; INHIBITION; MUSCLE; RODENT; SODIUM;

RATTUS;

EID: 55649125341     PISSN: 10184619     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Miller, RD. (1989) Basic and Clinical Pharmacology, ed., Katzung, B.G., Appletion and Lange, USA, pp. 323-333.
2. Taylor, P. (2001) In Goodman and Oilman's the Pharmacolgical Basis of Therapeutics, by Hardman JG, Limbird LE, ed., McGraw Hill, USA, pp. 193-213.
3. + in ileal longitudinal smooth muscle. Gen. Pharmacol., 27, 513-517.
4. Büyükokuroǧlu, M.E., G̈lçin, İ. Oktay, M. and Küfrevioǧlu, Ö.l̇. (2001) In vitro antioxidant properties of dantrolene sodium. Pharmacol. Res., 44, 491-494.
5. Wei H. and Perry D.C. (1996) Dantrolene is cytoprotective in two models of neuronal cell death. J. Neurochem., 67, 2390-2398.
6. Gunawardene R.D. and White, D.C. (1988) Propofol and emesis. Anaesthesia, 43, 65-67.
7. Langley, M.S. and Heel, R.C. (1988) Propofol A review of its pharmacodynamic and pharmacokinetic properties and use as an intravenous anaesthetic. Drugs, 35, 334-372.
8. Öztürk, E, Demirbilek, S., Buta, A., Sariçiçek, K.V., Güleç, M., Akyol, M. and Ersoy, O. (2005) Antioxidant properties of propofol and erythropoietin after closed head injury in rats. Prog. Neuro-Psychoph., 29, 922-927.
9. Weir, D.L., Goodcnild, C.S. and Graham, D.I. (1989) Propofol: Effects on indices of cerebral ischemia. J. Neurosurg, Anesthes., 1, 284-289.
10. Tsuchiya, M., Asada, A., Maeda, K., Ueda, Y., Sato, F.E., Shindo M. and Inoue M. (2001) Propofol versus midazolam regarding their antioxidant activities. Am. J. Respir. Crit. Care Med., 163, 26-31.
11. Gepts, E., Camu, F, Cockshott, I.D. and Douglas, E.J. (1987) Disposition of propofol administered as constant rate intravenous infusions in humans. Anesth. Analg. 66, 1256-1263.
12. Raoof, A.A., Obbergh, L.J., Ville de Goyet, J. and Verbeeck, R. (1996) Extrahepatic glucuronidation of propofol in man: possible contribution of gut wall and kidney. Eur. J. Clin. Pharmacol. 50, 91-96.
13. Guitton, J., Buronfosse, T., Desage, M., Flinois, J.P., Perdrix, J.P., Brazier J.L. and Beaune, P. (1998) Possible involvement of multiple human cytochrome P 450 isoforms in the liver metabolism of propofol. Br. J. Anesth. 80, 788-795.
14. Janicki, P.K., James, M.F. and Erskine, W.A. (1992) Propofol inhibits enzymatic degradation of alfentanil and sulfentanil by isolated liver microsomes in vitro. Br. J. Anesth. 68, 311-312.
15. Baker, M.T., Chada, M.V. and Ronnenberg, W.C. (1993) Inhibitory effects of propofol on cytochrome P 450 activities in rat hepatic microsomes. Anesth. Analg., 76, 817-821.
16. Leung, B.P., Miller E. and Park, G.R, (1997) The effect of propofol on midazolam metabolism in human liver microsome suspension. Anesthesia, 52, 945-948.
17. McKillop, D., Wild, M.J., Butters C.J. and Simocock, C. (1998) Effects of propofol on human hepatic microsomal cytochrome P450 activities. Xenobiotica, 28, 845-853.
18. Lejus, C., Fautrel, A., Malledant, Y. and Gufflouzo, A. (2002) Inhibition cytochrom P450 2E1 by ropofol in human and porcine liver microsomes. Biochem. Pharmacol., 64, 1151-1156.
19. Gemayel, J., Géloën, A. and Mion, F. (2001) Propofol-induced cytochrome P 450 inhibition an in vitro and in vivo study in rats. Life Sci., 68, 2957-2965.
20. Kutchai H, Geddis L.M. and Parley, R.A. (1999) Effects of general anaesthetics on the activity of the Na,K-ATPase of canine renal medulla. Pharmacol. Res., 40, 469-473.
21. Barren, M.P. (1997) The pentose phosphate pathway and parasitic Protozoa. Parasitol. Today, 13, 11-16.
22. Ohara, H., Russell, R.A., Uchida, K. and Kondo, H. (2004) Purification and characterization of NAD-specific 6-phosphogluconate dehydrogenase from Leuconostoc lactis SHO-54. J. Biosci. Bioeng., 98, 126-128.
23. Berdis, A.J. and Cook, P.F. (1993) The 29-phosphate of NADP is critical for optimum productive binding to 6-phosphogluconate dehydrogenase from Candida utilis. Arch. Biochem. Biophys., 305, 551-556.
24. Price, N. and Cook, P.F. (1996) Kinetics and chemical mechanisms of the sheepliver 6-phosphogluconate dehydrogenase. Arch. Biochem. Biophys., 336, 215-221.
25. Çiftçi, M, Beydemir, S., Yilmaz, H. and Bakan E. (2002) Effects of some drugs on rat erythrocyte 6-phosphogluconate dehydrogenase: an in vitro and in vivo study. Pol. J. Pharmacol., 54, 275-280.
26. Kahler, S.G. and Kirkman, H.N. (1983) Intracellular G6PD does not monomerize in human erythrocytes. J. Biol. Chem., 258, 717-718.
27. Takizawa, T., Huang I.V. and Ikuta, T. (1986) Human G6PD: Primary structure and cDNA cloning. Proc. Nat. Acad. Sci., 83, 4157-4162.
28. Kozar, R.A., Weibel, C.J., Cipolla, J., Klein, A.J.P., Haber, M.M., Abedin, M.Z. and Trooskin, S.Z. (2000) Antioxidant enzymes are induced during recovery from acute lung injury. Crit. Care Med., 28, 2486-2491.
29. Srivastava, S.K. and Beutler, E. (1989) Glutathione metabolism of the erythrocyte. The enzymic cleavage of glutathione-hemoglobin preparations by glutathione reductase. Biochem. J., 119, 353-358.
30. Beydemir, S, Gülçin, İ, Küfrevioǧlu, Ö.İ., and Çiftçi, M. (2003) Glucose 6-phosphate dehydrogenase: In vitro and in vivo effects of dantrolene sodium. Pol. J. Pharmacol., 55, 787-792.
31. Beydemir, S, M Çiftçi, Özmen, İ., Büyükoknroǧlu, M.E., Özdemir H. and Küfrevioǧ lu Öİ (2000) Effects of some medical drugs on enzyme activities of carbonic anhydrase from human erythrocytes in vitro and from rat erythrocyles in vivo. Pharmacol. Res., 42, 187-191.
32. Beutler, E. (1994) Glucose-6-phosphate dehydrogenase deficiency. Blood, 84, 3613-3616.
33. Puskas, F., Gergely, P.J., Banki K. and Perl, A. (2000) Stimulation of the pentose phosphate pathway and glutathione levels by dehydroascorbate, the oxidized form of vitamin C. FASEB J., 14, 1352-1361.
34. Çoban, T.A., Beydemir, S., Gülçin, İ. and Ekinci, D. (2007) Morphine inhibits erythrocyte carbonic anhydrase in vitro and in vivo. Biol. Pharm. Bull., 30(12), 2257-2261.
35. Delgado, C., Tejedor C. and Luquue, J. (1990) Partial purification of glucose-6-phosphate dehydrogenase from rat erythrocyte haemolysate by partitioning in aqueous two-phase system. J. Chromatogr., 498, 159-168.
36. Beydemir, S., Çiftçi, M., Küfrevioǧlu Ö.İ. and Büyükokuroǧlu, M.E. (2002) Effects of gentamicin sulfate on enzyme activities of carbonic anhydrase from human erythrocytes in vitro and from rat erythrocytes in vivo. Biol. Pharm. Bull., 25, 966-969.
37. Keha, E.E. and Küfrevioǧlu, Ö.İ. (2000) Biyokimya, (Turkish) 2nd ed., İstanbul, Aktif Yayinevi, pp 439.
38. Warnock, D.G. (1989) Diuretic Agent. In: Basic and Clinical Pharmacology, 4th ed., Katzung B.G., Appletion and Lange, USA, pp. 183-197.
39. Jayyosi, Z., Totis, M., Souhaili, H., Goulonginet, C., Livertoux, M.H., Batt, A. and Siest, G.M. (1987) Induction of hepatic cytochrome P-450c-dependent monooxygenase activities by dantrolene in rat. Biochem. Pharmacol., 15, 2481-2487.
40. Gupta, D.D., Saha, S. and Chakrabarti, M.K. (2005) Involvement of protein kinase C in the mechanism of action of Escherichia coli heat-stable enterotoxin (STa) in a human colonie carcinoma cell line, COLO-205. Toxicol. Appl. Pharmacol. 206, 9-16.
41. Gülçin, İ., Beydemir S. and Büyükokuroǧ lu M.E. (2004) In vitro and in vivo effects of dantrolene on carbonic anhydrase enzyme activities. Biol. Pharm. Bull. 27, 613-616.
42. 2+ toxicity. Ecotox. Environ. Saf., 57, 311-318.
43. Pasti, C., Rinaldi, E., Cervellati, C., Dallocchjo, F., Hardré, R., Salmonb L. and Hanau S., (2003) Sugar derivatives as new 6-phosphogluconale dehydrogenase inhibitors selective for the parasite Trypanosoma brucei. Bioorg. Med. Chem., 11, 1207-1214.
44. Niehaus, W.G., White, R.H., Richardson, S.B., Bourne, A. and Ray, W.K. (1995) Polyethylene sulfonate: A tightbinding inhibitor of 6-phosphogluconate dehydrogenase of Cryptococcus neaformans. Arch. Biochem. Biophys., 324, 325-330.
45. Carmona, A. and Freedland R.A. (1990) Effect of 6-aminonicotinamide on pentose cycle activity in isolated hepatocytes. Int. J. Biochem., 6, 595-599.